Top

Journal of Cancer Research and Clinical Oncology

Published in:

Open Access 01-11-2020 | Human Papillomavirus | Original Article – Cancer Research

Lysine-specific histone demethylase 1A (LSD1) in cervical cancer

Authors: Daniel Beilner, Christina Kuhn, Bernd P. Kost, Julia Jückstock, Doris Mayr, Elisa Schmoeckel, Christian Dannecker, Sven Mahner, Udo Jeschke, Helene Hildegard Heidegger

Published in: Journal of Cancer Research and Clinical Oncology | Issue 11/2020

Abstract

Purpose

Demethylation of DNA through enzymes like LSD1 showed a crucial impact on different kind of cancers. Epigenetic modifications in cervical cancer are still not fully investigated nevertheless of high interest for a therapeutic use.

Methods

Tumor samples of 250 cervical cancer patients were immunochemically stained and evaluated based on Immunoreactive Score. Results were statistically analyzed for clinical and pathological parameters.

Results

Our patient collective showed a disadvantage for 10-year survival for patients with a strong expression of LSD1 in the cytoplasm of cervical cancer cells. The results of the correlational analysis further revealed a negative correlation of LSD1 to G-protein coupled estrogen receptor (GPER).

Conclusions

Epigenetic changes through enzymes like LSD1 may also be of interest for patients with cervical cancer. A combined therapy with other proteins relayed to cervical cancer like GPER might be of interest for future investigations.

Ambrosio S, Sacca CD, Majello B (2017) Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A. Biochim Biophys Acta Gene Regul Mech 1860:905–910. https://doi.org/10.1016/j.bbagrm.2017.07.001CrossRefPubMed

Amente S, Lania L, Majello B (2013) The histone LSD1 demethylase in stemness and cancer transcription programs. Biochim Biophys Acta 1829:981–986. https://doi.org/10.1016/j.bbagrm.2013.05.002CrossRefPubMed

Aviel-Ronen S, Rubinek T, Zadok O, Vituri A, Avivi C, Wolf I, Barshack I (2016) Klotho expression in cervical cancer: differential expression in adenocarcinoma and squamous cell carcinoma. J Clin Pathol 69:53–57. https://doi.org/10.1136/jclinpath-2015-202929CrossRefPubMed

Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome—biological and translational implications. Nat Rev Cancer 11:726–734. https://doi.org/10.1038/nrc3130CrossRefPubMedPubMedCentral

Chan KKL et al (2017) Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis. BMC Cancer 17:606. https://doi.org/10.1186/s12885-017-3601-1CrossRefPubMedPubMedCentral

Fang Y, Liao G, Yu B (2019) LSD1/KDM1A inhibitors in clinical trials: advances and prospects. J Hematol Oncol 12:129. https://doi.org/10.1186/s13045-019-0811-9CrossRefPubMedPubMedCentral

Friese K et al (2018) The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer. J Cancer Res Clin Oncol 144:13–19. https://doi.org/10.1007/s00432-017-2510-7CrossRefPubMed

Goodman A (2015) HPV testing as a screen for cervical cancer. BMJ 350:h2372. https://doi.org/10.1136/bmj.h2372CrossRefPubMed

Gu F, Lin Y, Wang Z, Wu X, Ye Z, Wang Y, Lan H (2020) Biological roles of LSD1 beyond its demethylase activity. Cell Mol Life Sci. https://doi.org/10.1007/s00018-020-03489-9CrossRefPubMed

Hayami S et al (2011) Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer 128:574–586. https://doi.org/10.1002/ijc.25349CrossRefPubMed

Heublein S, Mayr D, Friese K, Jarrin-Franco MC, Lenhard M, Mayerhofer A, Jeschke U (2014) The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors. Int J Mol Sci 15:15161–15172. https://doi.org/10.3390/ijms150915161CrossRefPubMedPubMedCentral

Hsu LH, Chu NM, Kao SH (2017) Estrogen, estrogen receptor and lung cancer. Int J Mol Sci. https://doi.org/10.3390/ijms18081713CrossRefPubMedPubMedCentral

Jie D, Zhongmin Z, Guoqing L, Sheng L, Yi Z, Jing W, Liang Z (2013) Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Dig Dis Sci 58:1581–1589. https://doi.org/10.1007/s10620-012-2552-2CrossRefPubMed

Kim S et al (2019) Deregulation of the histone lysine-specific demethylase 1 is involved in human hepatocellular carcinoma. Biomolecules. https://doi.org/10.3390/biom9120810CrossRefPubMedPubMedCentral

Lan F, Nottke AC, Shi Y (2008) Mechanisms involved in the regulation of histone lysine demethylases. Curr Opin Cell Biol 20:316–325. https://doi.org/10.1016/j.ceb.2008.03.004CrossRefPubMedPubMedCentral

Leite KRM et al (2020) HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer. Acta Cytol. https://doi.org/10.1159/000506725CrossRefPubMed

Liu Y et al (2017) LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter. Oncotarget 8:11329–11342. https://doi.org/10.18632/oncotarget.13516CrossRefPubMed

Lv T, Yuan D, Miao X, Lv Y, Zhan P, Shen X, Song Y (2012) Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer. PLoS ONE 7:e35065. https://doi.org/10.1371/journal.pone.0035065CrossRefPubMedPubMedCentral

Munoz N et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527. https://doi.org/10.1056/NEJMoa021641CrossRefPubMed

Osborne C, Wilson P, Tripathy D (2004) Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9:361–377. https://doi.org/10.1634/theoncologist.9-4-361CrossRefPubMed

Payne SR, Kemp CJ (2005) Tumor suppressor genetics. Carcinogenesis 26:2031–2045. https://doi.org/10.1093/carcin/bgi223CrossRefPubMed

Shi Y et al (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941–953. https://doi.org/10.1016/j.cell.2004.12.012CrossRefPubMed

Taby R, Issa JP (2010) Cancer epigenetics. CA Cancer J Clin 60:376–392. https://doi.org/10.3322/caac.20085CrossRefPubMed

Weissenborn C, Ignatov T, Poehlmann A, Wege AK, Costa SD, Zenclussen AC, Ignatov A (2014) GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells. J Cancer Res Clin Oncol 140:663–671. https://doi.org/10.1007/s00432-014-1598-2CrossRefPubMed

Whyte WA et al (2012) Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 482:221–225. https://doi.org/10.1038/nature10805CrossRefPubMedPubMedCentral

World Health Organization [WHO] (2020a) CC, Available from: https://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/. Accessed 10 Apr 2020

World Health Organization [WHO] (2020b) IAfRoC, cancer today, Available from: https://gco.iarc.fr/today/online-analysis-table?v=2018&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=2&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1. Accessed 10 Apr 2020

Xu S, Yu S, Dong D, Lee LTO (2019) G protein-coupled estrogen receptor: a potential therapeutic target in cancer. Front Endocrinol (Lausanne) 10:725. https://doi.org/10.3389/fendo.2019.00725CrossRef

Yang GJ, Lei PM, Wong SY, Ma DL, Leung CH (2018) Pharmacological inhibition of LSD1 for cancer treatment. Molecules. https://doi.org/10.3390/molecules23123194CrossRefPubMedPubMedCentral

Yu X et al (2017) Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies. Breast Cancer 24:643–657. https://doi.org/10.1007/s12282-017-0789-5CrossRefPubMed

Zhang Q, Wu YZ, Zhang YM, Ji XH, Hao Q (2015) Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2. Cell Biochem Funct 33:134–142. https://doi.org/10.1002/cbf.3097CrossRefPubMed

Title: Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Authors: Daniel Beilner
Christina Kuhn
Bernd P. Kost
Julia Jückstock
Doris Mayr
Elisa Schmoeckel
Christian Dannecker
Sven Mahner
Udo Jeschke
Helene Hildegard Heidegger
Publication date: 01-11-2020
Publisher: Springer Berlin Heidelberg
Keywords: Human Papillomavirus
Cervical Cancer
Cervical Cancer
Epigenetics
Published in: Journal of Cancer Research and Clinical Oncology / Issue 11/2020
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-020-03338-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Lysine-specific histone demethylase 1A (LSD1) in cervical cancer

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2020

Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis

Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer

Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis

Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer

Low level expression of human telomerase reverse transcriptase predicts cancer-related death and progression in embryonal carcinoma

PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page